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Nuclear
phosphatidylinositol-5-phosphate
regulates ING2 stability at discrete
chromatin targets in response to DNA
damage
Dennis J. Bua, Gloria Mas Martin, Olivier Binda* & Or Gozani
Department of Biology, Stanford University, Stanford, CA 94305, USA.
ING2 (inhibitor of growth family member 2) is a component of a chromatin-regulatory complex that
represses gene expression and is implicated in cellular processes that promote tumor suppression. However,
few direct genomic targets of ING2 have been identified and the mechanism(s) by which ING2 selectively
regulates genes remains unknown. Here we provide evidence that direct association of ING2 with the
nuclear phosphoinositide phosphatidylinositol-5-phosphate (PtdIns(5)P) regulates a subset of ING2 targets
in response to DNA damage. At these target genes, the binding event between ING2 and PtdIns(5)P is
required for ING2 promoter occupancy and ING2-associated gene repression. Moreover, depletion of
PtdIns(5)P attenuates ING2-mediated regulation of these targets in the presence of DNA damage. Taken
together, these findings support a model in which PtdIns(5)P functions as a sub-nuclear trafficking factor
that stabilizes ING2 at discrete genomic sites.
C
hromatin structure plays a central role in the establishment, maintenance, and propagation of nuclear
programs and the dysregulation of gene expression programs occurs in numerous human pathologies,
including cancer. A key mechanism regulating chromatin structure involves the reversible covalent post-
translational modification (PTM) of histone proteins by chemical moieties such as acetyl- and methyl-groups.
Histone PTMs are dynamic, frequently changing in response to external cues1–3. For example, histone PTMs
acutely change during DNA damage responses (DDRs)4–6. A key question in understanding how nuclear pro-
grams, such as DDRs, are appropriately orchestrated is to identify how chromatin-regulatory activities are
specifically targeted and maintained at discrete chromosomal sites.
Inhibitor of Growth family member 2 (ING2) is a tumor suppressor protein7 that is a core component of a
multi-factor chromatin-modifying complex containing the transcriptional co-repressor SIN3A and HDAC1
(histone deacetylase 1)8. In response to DNA damage, ING2 associates with chromatin where it modulates
crosstalk between lysine methylation and lysine acetylation on histone proteins9. ING2 is stabilized at active
chromatin via its PHD (Plant homeodomain) finger9,10, which selectively binds to H3K4me3 (Histone H3
trimethylated on lysine 4), a hallmark of active transcription11,12. Genomic profiling of H3K4me3 patterns in a
variety of cell types conclude that H3K4me3 levels are high in the 59 region of nearly all actively expressed genes
and, consistently, H3K4me3 promoter enrichment correlates with active RNA polymerase occupancy, and
histone hyper-acetylation13. Thus, the interaction between ING2 and H3K4me3 (ING2::K4me3) stabilizes
ING2-SIN3A-HDAC1 complexes at target gene promoters, regions rich in acetylated histones, resulting in
histone deacetylation and gene repression9,14. However, the mechanism(s) that senses DNA damage and places
ING2 in the vicinity of H3K4me3-rich target gene promoters is not known.
Phospholipids, including phosphoinositides (PtdInsPs) play a pivotal role in cytoplasmic trafficking of intra-
cellular proteins15,16. While relatively little is known about the roles of nuclear PtdInsPs compared to their
cytosolic counterparts, recent evidence suggests that nuclear phosphoinositides control the localization of pro-
teins in the nucleus17–21. The direct interaction between ING2 and nuclear phosphatidylinositol-5-phosphate
(PtdIns(5)P) changes sub-nuclear distribution of ING2, which facilitates recruitment of ING2 to chromatin, and
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is required for ING2-associated activation of p53 during DDRs17,22,23.
Interestingly, levels of PtdIns(5)P undergo dynamic fluctuations
within the nucleus during DDRs. For example, etoposide, a topoi-
somerase inhibitor, increases the level of PtdIns(5)P in the chromatin
of human fibrosarcoma cells (HT1080)17. These observations suggest
a model in which dynamic changes in PtdIns(5)P levels couldmodu-
late selective chromatin targeting of ING2.
Here we demonstrate that the interaction between ING2 and nuc-
lear PtdIns(5)P (ING2::PtdIns(5)P) directly regulates chromatin-
mediated gene expression control. We first identify the DNA
damage-associated gene expression network mediated by ING2
and then uncover the subset of these genes that are specificallymodu-
lated by association of ING2with PtdIns(5)P. For this cluster, there is
a loss of ING2-associated gene repression when ING2::PtdIns(5)P is
disrupted or when nuclear PtdIns(5)P is metabolized. Loss of ING2
promoter occupancy is concomitant with abrogation of DNA
damage-induced histone deacetylation resulting in aberrant tran-
script elevation. Taken together, these findings establish PtdIns(5)P
as a new class of nuclear signaling molecules controlling gene
expression and provide mechanistic insight into the role of sub-
nuclear trafficking in the acute regulation of chromatin structure.
Results
Characterization of an ING2-associated DNA damage gene
expression program. To test the role of PtdIns(5)P-binding by
ING2 on ING2 gene expression functions, we determined the
ING2-mediated DNA damage program using a comprehensive
genomic approach coupling ChIP-chip (chromatin immunopreci-
pitation combined with tiling promoter DNA microarrays) and
gene expression microarray analyses. Combining these assays
allowed for the identification of gene promoters bound by ING2 as
well as the downstream transcriptional changes. Once we established
a baseline, we monitored changes to the ING2 expression network
resulting from perturbations in PtdIns(5)P signaling (diagrammed
in Figure S1).
For this study it was necessary to identify a form of ING2 that does
not bind PtdIns(5)P, but is not deficient in H3K4me3 binding. The
C-terminus of ING2 (Figure 1A) contains two conserved modules
(1) a PHD finger and (2) a polybasic region (PBR); within these
modules several key residues have been characterized for their role
in histone or lipid binding (see Figure 1B). For example, a specific
single amino acid change within the PHD finger (ING2D230A) abro-
gates ING2::H3K4me3 without ablation of ING2::PtdIns(5)P9. Here
we tested if a previously identified23 mutant deficient in PtdIns(5)P
binding (named ING26K/Rmt) can bind H3K4me3. Additionally we
generated and characterized amutant with the combined amino acid
changes in ING2D230A and ING26K/Rmt named ING2D-6K/Rmt. We
subjected the panel of ING2 mutants to in vitro histone peptide
(Figure 1C) and liposome pull-down assays (Figure 1D). As shown
in Figure 1C, ING26K/Rmt which fails to bind to PtdIns(5)P-contain-
ing liposomes, binds to H3K4me3 comparable to wild-type. In con-
trast, ING2D-6K/Rmt is deficient in binding to both H3K4me3 and
PtdIns(5)P (Figure 1C,D). Thus ING26K/Rmt and the other ING2
mutants can be used to isolate the impact of the ING2::PtdIns(5)P
on ING2 gene-regulatory functions. Next we generated human
fibrosarcoma cells (HT1080) stably-expressing epitope-tagged, full-
length wild-type ING2 (ING2WT) or ING26K/Rmut. Note that endo-
genous ING2 protein levels are depleted in response to ectopic
expression of wild-type and mutant ING2, thus the majority of
ING2 in the reconstituted cells is exogenous (Figure 1E; data not
shown).
Next, genome-wide promoter occupancy of ING2WT was deter-
mined. DNA that co-purified with FLAG-ING2WT in vehicle-treated
and etoposide-treated HT1080 cells was hybridized to Nimblegen
whole genome human promoter arrays and peaks were detected
using Nimblescan software. Significant ING2 peaks (see Methods)
were identified at over 200 unique promoters in etoposide-treated
cells, whereas no significant ING2 peaks were detected in vehicle-
treated cells (Supplementary Table 1).We hereafter refer to the set of
genes selectively bound by ING2 in the presence of etoposide as
ING2ET-BOUND targets.
Heatmap displays and average binding profiles were generated to
highlight ING2 occupancy within the promoters of ING2ET-BOUND
genes (Figure 2A; Figure S2). ING2 is enriched in promoters both
upstream and downstream of the transcriptional start site (TSS) with
decreased occupancy in the nucleosome-poor TSS, this is consistent
with the known distribution of H3K4me3 dictating ING2 occupancy
via the ING2::H3K4me3 interaction9,12,24. Next we tested if endogen-
ous ING2 behaves the same as FLAG-tagged ING2 at a novel ING2
target we identified: DKC1 (Figure 2B). The FLAG-ING2 ChIP-chip
data (Figure 2B top) is consistent with direct ChIP assays of endo-
genous ING2 (Figure 2B bottom): ING2 associates with the DKC1
promoter in the presence of etoposide with strong enrichment
upstream of the TSS. Collectively, we identified a cluster of over
two hundred novel gene promoters that ING2 selectively associates
with in the presence of DNA damage.
To determine if etoposide-induced ING2 occupancy results in a
functional change in transcription at ING2 target genes we per-
formed a series of gene expression microarray experiments. Note
that promoter occupancy was assayed 1 hr after etoposide treatment,
while gene expression analyses were monitored 20 hrs after etopo-
side treatment to allow for transcriptional responses to occur. Global
transcript profiling indicated that ING2ET-BOUND genes (Cluster A)
represent a statistically-significant (p 5 3.3E-11, Fisher’s exact test)
population of genes repressed in response to etoposide (Cluster B;
Figure 2C, top). Consistently, both of these gene clusters contain
enrichment of factors that modulate chromosome organization
and the cell cycle (Figure 2C, bottom). To further explore the rela-
tionship between ING2 promoter occupancy and transcriptional
repression we tested more promoter targets. Endogenous ING2 is
promoter-bound at AURKB (a representative from the cell cycle
cluster) and PCGF2 (a representative from the chromosome organ-
ization cluster), but not at ACTA, a negative control (Figure 2D).
ING2 occupancy correlates with a decrease in acetylated H3 at lysine
27 (H3K27Ac; Figure 2E). These data are consistent with ING2 being
present in an HDAC1 complex8,9,14. Taken together, these findings
support the notion that ING2 plays a key role in DNA damage-
induced gene repression, and this activity may be critical for ING2
tumor suppressive functions.
The ING2-PtdIns(5)P interaction is required for execution of the
ING2-associated DNA damage gene expression program. Based
on the observations that (1) ING2 dynamically associates with
chromatin in response to etoposide to repress transcription, and
(2) nuclear PtdIns(5)P levels increase in response to etoposide-
treatment, we postulated that DDR-induced ING2-PtdIns(5)P
interactions would regulate ING2 occupancy and/or activity at
target genes. To test this we performed global gene expression
analyses on cells expressing ING26K/Rmt. Transcript profiling
indicates that ablation of ING2::PtdIns(5)P results in impairment
of etoposide-induced nuclear programs (Figure 3). Since ING2 is
involved in gene repression, we focused on down-regulated
transcripts. Few down-regulated transcripts overlap (,15%) when
comparing cells expressing ING2WT to ING26K/Rmt, suggesting an
unraveling of the appropriate DNA-damage induced transcription
response in cells in which ING2 is unable to bind PtdIns(5)P
(Figure 3A). Heatmap analysis of cell cycle regulators (genes that
comprise Cluster B from Figure 1C) uncovered a striking
expression signature: loss of etoposide-induced repression in cells
expressing the ING2 lipid-binding mutant (Figure 3B); more
specifically, genes that are strongly repressed in response to
etoposide in ING2WT cells are aberrantly activated in ING26K/Rmt
www.nature.com/scientificreports
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Figure 1 | ING2 independently interacts with H3K4me3 and PtdIns(5)P. (A) (Top) Coomassie stain of GST-fused ING2 C-terminus constructs.
(Bottom) Schematic showing protein domain organization in the ING2 constructs. Asterisk indicates site ofmutagenesis in which the endogenous amino
acid is replaced with alanine: in the PHD domain D230A; in the PBR domain K272A, K274A, K275A, R277A, R278A, and R280A. (B) Table summarizing
GST-ING2 fusion binding activities. (C) Biotinylated histone pull-downs for ING2 constructs. (D) Liposome pull-downs for ING2 constructs.
(E) Immunoblot panel of HT1080 cell systems constitutively expressing ectopic ING2 forms. Uncropped images of blots are shown in Supp Figure 3.
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cells. Hereafter this expression pattern is called 5PRESS (transcripts
that require the binding event between ING2 and PtdIns(5)P for
repression in response to etoposide). Quantitative PCR transcript
(qPCR) analyses were performed on several ING2ET-BOUND targets
to confirm the 5PRESS expression signature (Figure 3C). In cells
treated with etoposide the transcript level of UBE2N and DKC1 are
similar in cells ectopically expressing ING2WT or ING26K/Rmt. In
contrast, the transcript levels of SKP2 and AURKB (5PRESS
targets) are elevated over 5-fold in cells expressing ING26K/Rmt
compared to cells expressing ING2WT. To summarize, transcript
analyses indicate that inhibition of the ING2-PtdIns(5)P interac-
tion results in aberrant DDR-induced gene repression.
One possible explanation for the defect in gene repression of cells
expressing ING26K/Rmt is that this mutant has decreased association
with HDAC activity. To investigate this possibility, a panel of ING2
complexes were purified then tested for in vitro HDAC activity
(Figure 3D). Compared to ING2WT, affinity-purified ING26K/Rmt
associated with comparable levels of HDAC1, SAP30, and SIN3A
(Figure 3D, top). Furthermore, affinity-purified ING26K/Rmt exhibits
in vitro histone deacetylase (HDAC) activity (on H3K9 and H3K27)
comparable to ING2WT (Figure 3D, bottom).We conclude that abla-
tion of ING2::PtdIns(5)P does not alter ING2-associated HDAC
activity. Taken together, these results strongly argue a direct role
for PtdIns(5)P in mammalian gene regulation.
PtdIns(5)P is required for stabilization at a spectrum of ING2
promoter targets. To focus functionally on the role of PtdIns(5)P
in selective gene repression we narrowed our attention to genes
directly bound by ING2 that require ING2::PtdIns(5)P for
repression (hereafter called ING25PRESS-BOUND; Figure 4A). More
specifically, ING25PRESS-BOUND targets: (1) are ING2ET-BOUND,
indicating that ING2 is selectively promoter-bound in the presence
of etoposide (Supp Figure 2, Supp Table1); (2) have a significant
transcript change determined by ANOVA (analysis of variance),
which accounts for inter- and intra-group variability of all the
microarrays used in this study; and (3) have the 5PRESS
expression signature. PtdIns(5)P modulates repression of ,10% of
ING2 direct targets, note the remaining ING2 targets are hereafter
referred to as ING2CONTROL-BOUND (Figure 4A).This group of genes
is involved in diverse cellular processes such as cell cycle control,
organelle homeostasis, and RNA processing (Figure 4A). Intrigu-
ingly, the ING2-PtdIns(5)P interaction is required for repression
of CIP2A (also known as KIAA1524), a putative oncogene that
promotes anchorage-independent growth25.
Our working model was that select ING2 targets require stable
association of ING2 with PtdIns(5)P to properly traffic ING2 to
the promoter (Figure 4B). To test our model we determined if abla-
tion of ING2::PtdIns(5)P would result in loss of ING2 pro-
moter targeting. Promoter occupancy for the ING2 panel was tested
at an ING25PRESS-BOUND representative, CIP2A, as well as an
ING2CONTROL-BOUND representative, UBE2N, in which ING2 pro-
moter occupancy should not be regulated by PtdIns(5)P (Figure 4C).
ING26K/Rmt associates with the promoter of UBE2N, but is not pro-
moter-bound at CIP2A. Furthermore, neither ING2D230A nor
ING2D-6K/Rmt are enriched compared to the control IP (FLAG-IP
from mock-transduced cells), which is consistent with the critical
role of H3K4me3::ING2 interaction in stabilizing ING2 at target
promoters. These data support the hypothesis that ING2::PtdIns(5)P
is required for promoter occupancy at discrete ING2 chromatin
targets.
Next we determined if chromatin trafficking of endogenous ING2
is impaired in an established cell-based system in which PtdIns(5)P
signaling is depleted due to over-expression of the human enzyme
phosphatidylinostiol-4-phosphate kinase II beta (PIP4Kbeta), which
utilizes PtdIns(5)P as a substrate to generate PtdIns(4,5)P217,26.
PIP4Kbeta expression abrogates association of endogenous ING2
with the ING25PRESS-BOUND representative, CIP2A, but not with
the ING2CONTROL-BOUND representative, UBE2N (Figure 4D top).
Furthermore in PIP4Kbeta-expressing HT1080 cells, acetylated his-
tone H4 (Acetyl-H4) levels are elevated exclusively at the CIP2A
promoter (Figure 4D bottom). These promoter changes have a func-
tional consequence on gene expression since ectopic PIP4Kbeta
results in a loss of DDR-induced gene repression for CIP2A, but
not UBE2N or PGK1, a gene not directly regulated by ING2
(Figure 4E). Thus, disrupting the interaction between ING2 and
PtdIns(5)P by two independent methods impairs the ability of
ING2 to bind and subsequently repress transcription of a subset of
ING2 target genes.
Discussion
An understanding of the gene network controlled by ING2 is critical
to unravel the molecular mechanism by which ING2 functions under
physiological conditions as a tumor suppressor protein. Here, we
uncovered several key features of the nuclear program mediated by
ING2 in response to DNA damage. We identified more than 200
novel gene promoters directly bound by ING2 in response to geno-
toxic stress. Consistent with tumor suppressive functions, ING2 reg-
ulates several key cellular processes including chromatin structure,
cell cycle progression, and cell proliferation. We focused on a group
of ING2 targets that are dependent on the nuclear lipid PtdIns(5)P for
proper regulation. The genes controlled by PtdIns(5)P are dysregu-
lated when either (1) the binding event between ING2 and PtdIns(5)P
is abrogated or (2) PtdIns(5)P levels are depleted due to PIP4Kbeta
over-expression. Together, our data suggest that PtdIns(5)P acts to
localize ING2 to target gene promoters which is instrumental in
focusing ING2-associated HDAC activity. PtdIns(5)P was discovered
nearly two decades ago27, and our work provides a new molecular
mechanism of how PtdIns(5)P can function in the context of signal
transduction within the nucleus.
Chromatin and phospholipid signaling networks impact gene
expression and dysregulation of either one of these networks can
contribute to human pathological states including cancer. ING2 is
of great interest because it is a direct integrator of chromatin and
nuclear phosphoinositide signaling networks and here we report that
these pathways converge to regulate the putative oncogene CIP2A.
Our data favor a model in which the ING2::PtdIns(5)P interaction
stabilizes ING2 at discrete sites within the nucleus, where ING2 can
then bind to H3K4me3 and anchor ING2-HDAC1-SIN3 complexes
at gene promoters. While this study identifies a specialized role for
ING2::PtdIns(5)P in gene expression control, it also highlights that
ING2::H3K4me3 may have a more general role in gene regulatory
functions. In Figure 4C we find that the mutant of ING2 unable to
bind H3K4me3 is not bound at either ING2 direct target. While
histone PTMs clearly have important roles in the stabilization and
maintenance of regulatory complexes on the chromatin template,
selective control of gene expression requires a large repertoire of
factors including DNA sequence-specific factors and other regulatory
cofactors28. Here we present evidence that nuclear phosphoinositides
may participate as regulatory cofactors playing a critical role in chro-
matin dynamics. In contrast to the numerous chromatin-binding
domains that have been characterized, few predominantly nuclear
lipid-binding proteins have been characterized. However, a recent
report elaborately employed a proteomic approach to identify over
one hundred nuclear proteins that interact with the phosphoinositide
PtdIns(4,5)P229. We speculate that follow-up studies on some of these
candidates, as well as discovery of additional PtdInsP-effectors, will
uncover the diversity of functions of nuclear PtdInsPs in gene regu-
lation and other fundamental nuclear processes.
Methods
Histone-peptide and liposome binding assays. Biotinylated H3 peptides and
histone-peptide binding assays have been described previously9. Lipids were
purchased from Echelon biosciences or Avanti Polar lipid. Liposome binding assays
www.nature.com/scientificreports
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Figure 4 | Select ING2 targets require PtdIns(5)P for promoter stabilization. (A) ING2 direct targets that require ING2-PtdIns(5)P for DNA damage-
induced repression (5PRESS-BOUND) are involved in diverse processes. Rep 5 Biological replicate. (B) Schematic of model in which ING2ET-BOUND
genes are divided into two groups. Predicted effect of PIP4Kbeta over-expression on ING2 target gene regulation is highlighted. (C) ING26K/Rmt is
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BOUND representative, CIP2A. Direct ChIP was performed with indicated antibodies in cells treated with etoposide. Data represent averages of 3
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were carried out essentially as described in30. Briefly, recombinant protein and
liposomes were combined in binding buffer (50 mM Tris, pH 7.5, 150 mM NaCl,
0.05% Nonidet P-40), rotated for 1 hr at room temperature, and then centrifuged at
13,000 rpm for 2 min. The liposome pellet was washed three times in 1 ml of binding
buffer. Liposome pellets were resolved by SDS-PAGE, and GST-fusion proteins were
detected by Immunoblot using an anti-GST antibody (Abcam).
ChIP and ChIP-chip.HT1080 cells were treated with Etoposide (100 uM) or vehicle
(DMSO) for 1 hr, then prepared as described previously for chromatin
immunoprecipitation (ChIP)31. Purified ChIP DNAwas quantified by real-time PCR
(RT-PCR) using a LightCycler 480 II (Roche) or a 7300 Real Time PCR machine
(Applied Biosystems). Primers are listed in SuppTable 3. For direct ChIP experiments
(unless otherwise indicated), a representative experiment is shown with error bars
indicating standard error of the mean (s.e.m.) of three technical replicates. ChIP-chip
assays were performed as previously31. Briefly, ChIP DNA purified as described
above, then amplified (Sigma Whole Genome Amplification kits 2 and 3), labeled,
and hybridized to Roche Nimblegen 385 K RefSeq promoter arrays. ChIP-chip peaks
were identified using the Nimblescan algorithm according to the standard
manufacturer’s protocol. A peak must have a minimum of four consecutive ChIP-
chip probes where the log2 ratio of ChIP to input signal is between 20-90% of the
hypothetical maximum log2 ratio (the mean log2 ratio of the array 1 6 standard
deviations). The false discovery rate (FDR) for each peak was calculated by
permutations of the data within each chromosome, our cutoff was FDR less than or
equal to 0.2. We applied an additional cutoff which required the fourth highest probe
within the peak to have a log2 ratio . 0.5 (ING2 ChIP/Input chromatin). To be a
significant ING2 peak, the gene had to meet all of the criteria above in both biological
replicates.
Antibodies and Plasmids. ING2 and derivative constructs were previously
described9,23. PIP4Kbeta and derivative constructs were previously described or sub-
cloned into: pBabe with FLAG-HA epitopes9,23. Mutants were made by PCR-
mediated site-directed mutagenesis (Stratagene). Antibodies used in this study:
ING223, H3K4me3 (Active Motif); SAP30, HDAC1 and Acetyl-H4 (Millipore);
Tubulin (Upstate); H3, H3K27ac, HDAC1 and SIN3A (Abcam); Rabbit IgG, FLAG
M2 and H3K9ac (Sigma).
Transcript analyses. RNA was isolated using RNeasy plus kits (Qiagen). For gene
expression microarrays, RNA was processed for use with Illumina Bead Arrays per
manufacturer’s instructions. Probe-level data were processed using Genespring
software and all subsequent analyses were performed using MeV32,33. Gene Ontology
(GO) analysis was performed using the DAVID Bioinformatics Resource34,35. For
quantitative transcript analysis by qPCR, RNA was isolated as above and then
converted toDNAusing the Superscript III first-strand synthesis system (Invitrogen).
Primer pairs and Roche Universal Probe information are listed in Supplementary
Table 3. The comparative threshold method was used for relative quantification and
each gene was normalized to GAPDH. Unless otherwise stated, a representative
experiment is presented with error bars indicating s.e.m. of three technical replicates.
Cell culture, transient transfection, viral transduction, enzymatic assays. 293T and
HT1080 cell lines (ATCC) were cultured in Advanced DMEM (Invitrogen)
supplemented with penicillin-streptomycin (Invitrogen), glutamine (Invitrogen),
and 10% newborn calf serum (Atlanta). Transient transfection, retroviral
transduction, and histone deacetylation (HDAC) reactions were performed as
previously described9. For HDAC reactions, full-length FLAG-ING2 complexes were
purified from mammalian cells lysed in buffer (50 mM Tris-HCl (pH7.4), 250 mM
NaCl, 0.5% Triton X-100, 10% glycerol, 1 mM PMSF, Protease Inhibitors (Roche))
using anti-FLAG M2-conjugated agarose (Sigma) and eluted with 0.4 mg/ml FLAG
peptide. The substrate used was calf thymus histones (Worthington) and where
indicated the reactions were performed in the presence of 330 nM trichostatin A
(Sigma).
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